Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
34.38
+2.60 (8.18%)
Mar 4, 2026, 4:00 PM EST - Market closed
Liquidia Market Cap
Liquidia has a market cap or net worth of $3 billion as of March 4, 2026. Its market cap has increased by 118.71% in one year.
Market Cap
3.00B
Enterprise Value
2.97B
1-Year Change
118.71%
Ranking
Category
Stock Price
$34.38
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $3.00B, an increase of 1,687.36%. That is a compound annual growth rate of 46.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 2.76B | -7.86% |
| Dec 31, 2025 | 3.00B | 201.46% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IDEAYA Biosciences | 3.01B |
| Viridian Therapeutics | 3.00B |
| Arcutis Biotherapeutics | 2.93B |
| Catalyst Pharmaceuticals | 2.92B |
| Arcus Biosciences | 2.81B |
| Vera Therapeutics | 2.80B |
| Beam Therapeutics | 2.70B |
| Travere Therapeutics | 2.61B |